NCT06232291Completed
Observation of Safety and Tolerability Within 1 Year of the Use of R-ketamine / Placebo in Drug-resistant Depression
Source: ClinicalTrials.gov · Last updated 29 May 2024
Brief summary (registry, in English)
An observational-comparative study, without interfering with the treatment, based on an operationalized interview.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 3 (actual)
- First submitted
- 22 Jan 2024
- Start date
- 21 Apr 2023
- Primary completion date
- 24 May 2024
- Lead sponsor
- Medical University of Gdansk
- Diseases
- Depression
- NCT number
- NCT06232291
What you commit to
- Study type: Observational
- Participants enrolled: 3
- From 21 Apr 2023 to the primary completion date, 24 May 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Informed consent withdrawal.
Who the study is looking for
- Expressing informed consent to participate in the study and earlier participation in the PCN-101-21 study on site.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University Of Gdansk Coordinator of this site? Confirm its status | Gdansk | Poland | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.